Interleukin-10-based therapy for inflammatory bowel disease (Q35184708)

7 August 2017

1 reference

title

Interleukin-10-based therapy for inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

7 August 2017

main subject

0 references

Henri Braat

1

0 references

Maikel P Peppelenbosch

object named as

Maikel P Peppelenbosch

series ordinal

2

0 references

author name string

Daan W Hommes

series ordinal

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Expert Opinion on Biological Therapy

7 August 2017

published in

1 reference

7 August 2017

volume

3

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

725-731

1 reference

Taming the mucosal immune response in Crohn's disease

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Dendritic cells as a tool to induce anergic and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

IL-10 gene therapy prevents TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Interleukin 10 gene transfer prevents experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

A receptor for interleukin 10 is related to interferon receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Dendritic cell regulation of TH1-TH2 development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

A unique subset of self-specific intraintestinal T cells maintains gut integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Interleukin 10 is a growth factor for a population of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Altered immune responses in interleukin 10 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Preclinical safety evaluation of recombinant human interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Anatomical basis of tolerance and immunity to intestinal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

Regulators split on gene therapy as patient shows signs of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.725

21 January 2018

Identifiers

DOI

10.1517/14712598.3.5.725

1 reference

7 August 2017

1 reference